Home2019-05-06T17:26:12+00:00
Loading...

Spotlight

Twitter feed

Ms. Connie Szczepanek Receives Partners in Progress Award for Pivotal Clinical Trial Work: #ASCOdailynews #ASCO19 #cancerresearch

Ms. Connie Szczepanek Receives Partners in Progress Award for Pivotal Clinical Trial Work

bit.ly

#ASCOconnection editor in chief @LDuska shares how being present and following your passions can lead you to your dream career

Finding My Niche

How my passions became my career path.

bit.ly

Using Tumor Genomic Profiling to Guide Treatment Selection Extends Survival in Advanced Sarcoma: #ASCOdailynews #ASCO19 #genetics #genetictesting #sarcoma #scmsm

Using Tumor Genomic Profiling to Guide Treatment Selection Extends Survival in Advanced Sarcoma

bit.ly

Early Initiation of MRI-Based Breast Cancer Screening Predicted to Halve Breast Cancer Deaths in Childhood Cancer Survivors: #ASCOdailynews #ASCO19 #bcsm #breastcancer #childhoodcancer #MRI #survivorship

Early Initiation of MRI-Based Breast Cancer Screening Predicted to Halve Breast Cancer Deaths in Childhood Cancer Survivors

bit.ly

Recent publications

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium. Ann. Oncol.

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Lancet Oncol.

All publications

Announcements

Please check back soon for new announcements

Research

Target identification and validation image
Target identification and validation
Photo of scientist carefully adding fluid to multiple test tubes
Drug discovery and development
Photo of Belfer Center researcher working at computer
Clinical science and correlatives

Strategic alliances

Graphic showing circular relationship of research, medicine, and industry

Our strategic alliances drive research innovations and lead to improved therapies to benefit cancer patients

Collaborate with us

Our people

Background image is a collage of photos showing Belfer Center members

Donor highlight

Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.

Photo of donors, Mr. and Mrs Belfer